- Corporate Officers - F
- Febbo Phillip G.
Insider Trading History of Febbo Phillip G.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Febbo Phillip G. since 2016.
This trader's CIK number is 1649245.
At the time of last reporting, Febbo Phillip G. was the Chief Scientific & Med Officer of Veracyte, Inc.. (stock ticker symbol VCYT).
Also see all insider trading activities at Veracyte, Inc..
Note that in the past
Febbo Phillip G. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genomic Health Inc (GHDX) by Febbo Phillip G.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | GHDX | 0 | $0 | 4,942 | $163,471 | 0 | $0 |
| 2017 | GHDX | 0 | $0 | 11,003 | $378,508 | 5,000 | $135,000 |
| 2016 | GHDX | 0 | $0 | 6,324 | $174,915 | 0 | $0 |
Yearly summary of insider trading at Illumina, Inc. (ILMN) by Febbo Phillip G.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ILMN | 0 | $0 | 0 | $0 | 3,522 | $0 |
| 2022 | ILMN | 0 | $0 | 1,988 | $715,699 | 0 | $0 |
| 2021 | ILMN | 0 | $0 | 2,000 | $854,443 | 3,173 | $0 |
| 2020 | ILMN | 0 | $0 | 328 | $99,965 | 0 | $0 |
| 2019 | ILMN | 0 | $0 | 155 | $46,500 | 0 | $0 |
Yearly summary of insider trading at Varian Medical Systems Inc (VAR) by Febbo Phillip G.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | VAR | 0 | $0 | 0 | $0 | 1,225 | $0 |
| 2020 | VAR | 0 | $0 | 0 | $0 | 474 | $0 |
Yearly summary of insider trading at Veracyte, Inc. (VCYT) by Febbo Phillip G.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | VCYT | 0 | $0 | 8,037 | $268,500 | 0 | $0 |
| 2024 | VCYT | 0 | $0 | 3,934 | $173,446 | 0 | $0 |
Insider trading activities at 4 companies by Febbo Phillip G.:
1. Genomic Health Inc (GHDX)
2. Illumina, Inc. (ILMN)
3. Varian Medical Systems Inc (VAR)
4. Veracyte, Inc. (VCYT)
Table 1. Insider trading of Genomic Health Inc (GHDX) by Febbo Phillip G.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-02-20 | GHDX | Sale | 4,942 | 33.08 | 163,471 |
| 2017-12-19 | GHDX | Option Ex | 5,000 | 27.00 | 135,000 |
| 2017-12-19 | GHDX | Sale | 5,334 | 36.91 | 196,877 |
| 2017-07-19 | GHDX | Sale | 3,174 | 33.57 | 106,544 |
| 2017-02-16 | GHDX | Sale | 2,495 | 30.09 | 75,087 |
| 2016-05-10 | GHDX | Sale | 6,324 | 27.66 | 174,915 |
Table 2. Insider trading of Illumina, Inc. (ILMN) by Febbo Phillip G.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-02-21 | ILMN | Option Ex | 3,522 | .00 | 0 |
| 2022-04-06 | ILMN | Sale | 1,988 | 360.01 | 715,699 |
| 2021-11-08 | ILMN | Sale | 1,000 | 406.83 | 406,830 |
| 2021-06-11 | ILMN | Sale | 1,000 | 447.61 | 447,613 |
| 2021-02-17 | ILMN | Option Ex | 3,173 | .00 | 0 |
| 2020-11-06 | ILMN | Sale | 155 | 310.10 | 48,065 |
| 2020-04-16 | ILMN | Sale | 173 | 300.00 | 51,900 |
| 2019-11-14 | ILMN | Sale | 155 | 300.00 | 46,500 |
Table 3. Insider trading of Varian Medical Systems Inc (VAR) by Febbo Phillip G.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-16 | VAR | Option Ex | 1,225 | .00 | 0 |
| 2020-02-14 | VAR | Option Ex | 474 | .00 | 0 |
Table 4. Insider trading of Veracyte, Inc. (VCYT) by Febbo Phillip G.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-04 | VCYT | Sale | 8,037 | 33.41 | 268,500 |
| 2024-12-04 | VCYT | Sale | 3,934 | 44.09 | 173,446 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Febbo Phillip G.
(Chief Scientific & Med Officer of Veracyte, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.